Published in Science on December 20, 1996
Putting tumours in context. Nat Rev Cancer (2001) 12.37
Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci U S A (2001) 7.93
Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu Rev Cell Dev Biol (2006) 6.64
Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci U S A (2003) 6.35
Influence of tumour micro-environment heterogeneity on therapeutic response. Nature (2013) 4.78
Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev (2009) 4.29
Tumors as organs: complex tissues that interface with the entire organism. Dev Cell (2010) 3.98
Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? Cancer Cell (2005) 3.67
Immuno-LCM: laser capture microdissection of immunostained frozen sections for mRNA analysis. Am J Pathol (1999) 2.59
p16(INK4a) prevents centrosome dysfunction and genomic instability in primary cells. PLoS Biol (2006) 2.39
Gene expression signatures of morphologically normal breast tissue identify basal-like tumors. Breast Cancer Res (2006) 2.12
Clinical implications and utility of field cancerization. Cancer Cell Int (2007) 1.91
Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue. Breast Cancer Res Treat (2009) 1.83
Fibronectin expression modulates mammary epithelial cell proliferation during acinar differentiation. Cancer Res (2008) 1.81
The tumor microenvironment is a dominant force in multidrug resistance. Drug Resist Updat (2012) 1.77
Targeting breast cancer stem cells. Mol Oncol (2010) 1.72
Host microenvironment in breast cancer development: extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast. Breast Cancer Res (2003) 1.53
Laser capture microdissection in pathology. J Clin Pathol (2000) 1.50
Biospecimen reporting for improved study quality (BRISQ). J Proteome Res (2011) 1.48
Telomere shortening occurs in subsets of normal breast epithelium as well as in situ and invasive carcinoma. Am J Pathol (2004) 1.44
Microbeam MOMeNT: non-contact laser microdissection of membrane-mounted native tissue. Am J Pathol (1997) 1.41
Tissue architecture: the ultimate regulator of epithelial function? Philos Trans R Soc Lond B Biol Sci (1998) 1.40
Single nucleotide polymorphism array analysis of flow-sorted epithelial cells from frozen versus fixed tissues for whole genome analysis of allelic loss in breast cancer. Am J Pathol (2002) 1.39
High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss. Am J Pathol (2001) 1.36
Phenotypic and functional characterization of human mammary stem/progenitor cells in long term culture. PLoS One (2009) 1.33
Structural cues from the tissue microenvironment are essential determinants of the human mammary epithelial cell phenotype. J Mammary Gland Biol Neoplasia (1998) 1.30
Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis. Proc Natl Acad Sci U S A (1997) 1.29
Breast tumour angiogenesis. Breast Cancer Res (2007) 1.22
The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions. Breast Cancer Res (2003) 1.20
The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies. Exp Mol Pathol (2009) 1.18
Methylation of hMLH1 promoter correlates with the gene silencing with a region-specific manner in colorectal cancer. Br J Cancer (2002) 1.16
The Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center: a unique resource for defining the "molecular histology" of the breast. Cancer Prev Res (Phila) (2012) 1.15
DNA demethylation in normal colon tissue predicts predisposition to multiple cancers. Oncogene (2012) 1.15
Multistep tumorigenesis and the microenvironment. Breast Cancer Res (2004) 1.14
Biospecimen Reporting for Improved Study Quality. Biopreserv Biobank (2011) 1.12
Colon cancer stem cells: implications for prevention and therapy. Trends Mol Med (2008) 1.12
Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins. Gut (2006) 1.11
Differential patterns of allelic loss in estrogen receptor-positive infiltrating lobular and ductal breast cancer. Genes Chromosomes Cancer (2008) 1.10
Concordance of metabolic enzyme genotypes assayed from paraffin-embedded, formalin-fixed breast tumors and normal lymphatic tissue. Clin Epidemiol (2010) 1.06
Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones. Endocr Relat Cancer (2000) 1.06
Gene expression profiles of estrogen receptor-positive and estrogen receptor-negative breast cancers are detectable in histologically normal breast epithelium. Clin Cancer Res (2010) 1.05
Loss of heterozygosity or allele imbalance in histologically normal breast epithelium is distinct from loss of heterozygosity or allele imbalance in co-existing carcinomas. Am J Pathol (2002) 1.05
The clonal origin and clonal evolution of epithelial tumours. Int J Exp Pathol (2000) 1.04
Allelic loss on chromosome band 18p11.3 occurs early and reveals heterogeneity in breast cancer progression. Breast Cancer Res (2001) 1.04
Genetically abnormal clones in histologically normal breast tissue. Am J Pathol (1998) 1.03
In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology. Mol Cell Proteomics (2010) 1.03
Genomic alterations in sporadic synchronous primary breast cancer using array and metaphase comparative genomic hybridization. Neoplasia (2007) 1.01
Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients. BMC Cancer (2010) 0.99
Tamoxifen induces pleiotrophic changes in mammary stroma resulting in extracellular matrix that suppresses transformed phenotypes. Breast Cancer Res (2009) 0.99
Colon cancer stem cells. Gastrointest Cancer Res (2010) 0.98
The long and short of chromosome 11 in breast cancer. Am J Pathol (1998) 0.96
Quantitative evaluation of DNA hypermethylation in malignant and benign breast tissue and fluids. Int J Cancer (2010) 0.95
Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype. Br J Cancer (2008) 0.95
Loss of heterozygosity in fibrocystic change of the breast: genetic relationship between benign proliferative lesions and associated carcinomas. Am J Pathol (2000) 0.94
Nuclear nano-morphology markers of histologically normal cells detect the "field effect" of breast cancer. Breast Cancer Res Treat (2012) 0.93
Chromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological features. Mol Pathol (2001) 0.92
Mapping loss of heterozygosity in normal human breast cells from BRCA1/2 carriers. Br J Cancer (2006) 0.92
AKT1/BRCA1 in the control of homologous recombination and genetic stability: the missing link between hereditary and sporadic breast cancers. Oncotarget (2010) 0.91
Selective regain of egfr gene copies in CD44+/CD24-/low breast cancer cellular model MDA-MB-468. BMC Cancer (2010) 0.91
Increased invasiveness and aggressiveness in breast epithelia with cytoplasmic p63 expression. Int J Biol Sci (2010) 0.91
Elevated retinoic acid receptor beta(4) protein in human breast tumor cells with nuclear and cytoplasmic localization. Proc Natl Acad Sci U S A (1999) 0.90
Loss of heterozygosity on chromosome 11p15 during histological progression in microdissected ductal carcinoma of the breast. Am J Pathol (1998) 0.90
Breast cancer, stem cells and prospects for therapy. Breast Cancer Res (2006) 0.90
Biallelic inactivation of retinoic acid receptor beta2 gene by epigenetic change in breast cancer. Am J Pathol (2001) 0.89
Using germline genotype in cancer pharmacogenetic studies. Pharmacogenomics (2009) 0.89
Aberrant c-erbB2 expression in cell clusters overlying focally disrupted breast myoepithelial cell layers: a trigger or sign for emergence of more aggressive cell clones? Int J Biol Sci (2008) 0.88
Characterization of tumor progression in engineered tissue using infrared spectroscopic imaging. Analyst (2010) 0.87
Relationship of vascular maturation in breast cancer blood vessels to vascular density and metastasis, assessed by expression of a novel basement membrane component, LH39. Br J Cancer (2000) 0.87
Genomic aberrations in normal tissue adjacent to HER2-amplified breast cancers: field cancerization or contaminating tumor cells? Breast Cancer Res Treat (2012) 0.86
Spontaneous slow replication fork progression elicits mitosis alterations in homologous recombination-deficient mammalian cells. Proc Natl Acad Sci U S A (2013) 0.85
A developmental hypothesis to explain the multicentricity of breast cancer. CMAJ (1998) 0.85
Breast cancer genomes--form and function. Curr Opin Genet Dev (2010) 0.85
In vitro models of tumor vessels and matrix: engineering approaches to investigate transport limitations and drug delivery in cancer. Adv Drug Deliv Rev (2013) 0.85
Mutations in normal breast tissue and breast tumours. Breast Cancer Res (2001) 0.84
Considerations for accurate gene expression measurement by reverse transcription quantitative PCR when analysing clinical samples. Anal Bioanal Chem (2014) 0.84
M6P/IGF2R loss of heterozygosity in head and neck cancer associated with poor patient prognosis. BMC Cancer (2003) 0.84
Genomic instability demonstrates similarity between DCIS and invasive carcinomas. Breast Cancer Res Treat (2008) 0.84
Comparison of Random Periareolar Fine Needle Aspirate versus Ductal Lavage for Risk Assessment and Prevention of Breast Cancer. Curr Breast Cancer Rep (2012) 0.83
Prognostic significance of the allelic loss of the BRCA1 gene in colorectal cancer. Gut (2003) 0.83
Passenger mutations as a marker of clonal cell lineages in emerging neoplasia. Semin Cancer Biol (2010) 0.83
Novel molecular markers of malignancy in histologically normal and benign breast. Patholog Res Int (2011) 0.82
Mitochondrial D310 mutations in the early development of breast cancer. Br J Cancer (2012) 0.82
Clonality Studies in the Analysis of Adrenal Medullary Proliferations: Application Principles and Limitations. Endocr Pathol (1998) 0.81
KRAS Mouse Models: Modeling Cancer Harboring KRAS Mutations. Genes Cancer (2011) 0.81
The biological sense of cancer: a hypothesis. Theor Biol Med Model (2006) 0.81
The Stem Cell Network model: clinical implications in cancer. Eur Arch Otorhinolaryngol (2008) 0.80
Mammary cancer and epithelial stem cells: a problem or a solution? Breast Cancer Res (2002) 0.80
Loss of heterozygosity at chromosome 9p in ductal carcinoma in situ and invasive carcinoma of the breast. Br J Cancer (1998) 0.80
Signatures of post-zygotic structural genetic aberrations in the cells of histologically normal breast tissue that can predispose to sporadic breast cancer. Genome Res (2015) 0.80
Intraductal proliferative lesions of the breast-terminology and biology matter: premalignant lesions or preinvasive cancer? Int J Surg Oncol (2012) 0.80
Mammary development and breast cancer: the role of stem cells. Curr Mol Med (2011) 0.80
Malignant transformation and stromal invasion from normal or hyperplastic tissues: true or false? J Cancer (2011) 0.79
Breast Cancer beyond the Age of Mutation. Gerontology (2015) 0.78
Biomarkers and the genetics of early neoplastic lesions. Cancer Biomark (2010) 0.78
Topographic enhancement mapping of the cancer-associated breast stroma using breast MRI. Integr Biol (Camb) (2011) 0.78
Multiplex genotype analysis of invasive carcinoma and accompanying proliferative lesions microdissected from breast tissue. J Mol Diagn (2000) 0.78
The role of microsatellite instability at chromosome 11p15.5 in the progression of breast ductal carcinoma. J Korean Med Sci (2004) 0.78
Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer. Breast Cancer (Auckl) (2016) 0.77
Destructive impact of T-lymphocytes, NK and Mast cells on basal cell layers: implications for tumor invasion. BMC Cancer (2013) 0.77
Characterizing the heterogeneity of triple-negative breast cancers using microdissected normal ductal epithelium and RNA-sequencing. Breast Cancer Res Treat (2013) 0.77
Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies. J Virol (1999) 9.11
RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell (1999) 8.55
Whole-Organ Magnetic Resonance Imaging Score (WORMS) of the knee in osteoarthritis. Osteoarthritis Cartilage (2004) 8.50
The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J (2001) 7.97
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat Med (2000) 7.48
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature (2000) 6.70
PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet (1999) 6.18
Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science (1999) 6.04
Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci U S A (1994) 5.74
Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med (1998) 5.54
Accurate assessment of precision errors: how to measure the reproducibility of bone densitometry techniques. Osteoporos Int (1995) 5.22
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 4.67
Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome. Nat Genet (1995) 4.45
Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Natl Cancer Inst (1995) 3.96
Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology (2006) 3.93
Integrating primary medical care with addiction treatment: a randomized controlled trial. JAMA (2001) 3.91
c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N Engl J Med (1994) 3.89
Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci U S A (2000) 3.61
Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat Genet (1996) 3.58
Latent and active p53 are identical in conformation. Nat Struct Biol (2001) 3.47
Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines. J Natl Cancer Inst (1977) 3.35
ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc Natl Acad Sci U S A (1992) 3.25
Axon-glia interactions and the domain organization of myelinated axons requires neurexin IV/Caspr/Paranodin. Neuron (2001) 3.20
Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res (1994) 3.18
Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection. Am J Med (1993) 2.96
Assessment of rheumatoid arthritis using a modified scoring method on digitized and original radiographs. Arthritis Rheum (1998) 2.91
RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun (2002) 2.88
Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol (2000) 2.73
Contrast extravasation on CT predicts mortality in primary intracerebral hemorrhage. AJNR Am J Neuroradiol (2007) 2.69
Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells. Am J Transplant (2007) 2.61
Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. J Virol (1997) 2.59
The Dentin matrix protein 1 (Dmp1) is specifically expressed in mineralized, but not soft, tissues during development. J Dent Res (2003) 2.48
Induction of cell division in medium lacking serum growth factor by SV40. Virology (1971) 2.48
Noninvasive assessment of bone mineral and structure: state of the art. J Bone Miner Res (1996) 2.47
Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest (2001) 2.45
Identification of a putative alternate sigma factor and characterization of a multicomponent regulatory cascade controlling the expression of Pseudomonas syringae pv. syringae Pss61 hrp and hrmA genes. J Bacteriol (1994) 2.45
Identification of a PY motif in the epithelial Na channel subunits as a target sequence for mutations causing channel activation found in Liddle syndrome. EMBO J (1996) 2.39
Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol (2001) 2.33
Epithelial cell cultures from normal glandular tissue of mice. J Natl Cancer Inst (1974) 2.32
The Alzheimer's peptide a beta adopts a collapsed coil structure in water. J Struct Biol (2000) 2.26
Regulation of the Bacillus subtilis pyrimidine biosynthetic (pyr) gene cluster by an autogenous transcriptional attenuation mechanism. J Bacteriol (1994) 2.17
Discs Lost, a novel multi-PDZ domain protein, establishes and maintains epithelial polarity. Cell (1999) 2.16
A de novo missense mutation of the beta subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity. Proc Natl Acad Sci U S A (1995) 2.10
Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification. J Bone Miner Res (1997) 2.09
Premedication with intravenous dexmedetomidine-midazolam suppresses fentanyl-induced cough. Ir J Med Sci (2012) 2.06
Organization and environmental regulation of the Pseudomonas syringae pv. syringae 61 hrp cluster. J Bacteriol (1992) 2.02
Identification of a novel human Rho protein with unusual properties: GTPase deficiency and in vivo farnesylation. Mol Cell Biol (1996) 1.98
Myoblast city, the Drosophila homolog of DOCK180/CED-5, is required in a Rac signaling pathway utilized for multiple developmental processes. Genes Dev (1998) 1.97
Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. AJR Am J Roentgenol (1998) 1.94
Identification of confounders in the assessment of the relationship between lead exposure and child development. Ann Epidemiol (2001) 1.93
p53 gene mutations and protein accumulation in human ovarian cancer. Proc Natl Acad Sci U S A (1993) 1.93
Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol (2001) 1.89
The human homologue for the Caenorhabditis elegans cul-4 gene is amplified and overexpressed in primary breast cancers. Cancer Res (1998) 1.88
Epithelial cell cultures from normal and cancerous human tissues. J Natl Cancer Inst (1976) 1.86
Volumetric quantitative computed tomography of the proximal femur: precision and relation to bone strength. Bone (1997) 1.84
Abortive infection of Escherichia coli strain W by T2 bacteriophage. J Mol Biol (1968) 1.84
Anterior-posterior and rotational displacement of the tibia elicited by quadriceps contraction. Am J Sports Med (1992) 1.84
Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphatidylinositol 3-kinase. J Biol Chem (2001) 1.82
miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells. Cell Death Differ (2009) 1.82
Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. J Clin Invest (2000) 1.82
Linking molecular therapeutics to molecular diagnostics: inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells in vitro and in vivo. Proc Natl Acad Sci U S A (2001) 1.82
In vitro selection and characterization of a highly efficient Zn(II)-dependent RNA-cleaving deoxyribozyme. Nucleic Acids Res (2000) 1.80
Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors. Clin Cancer Res (1996) 1.77
A-Type proanthocyanidin trimers from cranberry that inhibit adherence of uropathogenic P-fimbriated Escherichia coli. J Nat Prod (2000) 1.74
MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. Oncogene (2012) 1.74
Universal standardization of bone density measurements: a method with optimal properties for calibration among several instruments. J Bone Miner Res (1997) 1.73
Accumulation of a protein required for division during the cell cycle of Escherichia coli. J Bacteriol (1970) 1.71
Antibody-induced epidermal growth factor receptor dimerization mediates inhibition of autocrine proliferation of A431 squamous carcinoma cells. J Biol Chem (1994) 1.69
Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus. Proc Natl Acad Sci U S A (1999) 1.68
Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol (2001) 1.64
p21(WAF1) and transforming growth factor-alpha mediate dietary phosphate regulation of parathyroid cell growth. Kidney Int (2001) 1.63
DNA amplification is rare in normal human cells. Proc Natl Acad Sci U S A (1990) 1.63
Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc Natl Acad Sci U S A (1986) 1.62
An open-label, parallel, multiple-dose study comparing the pharmacokinetics and gastric acid suppression of rabeprazole extended-release with esomeprazole 40 mg and rabeprazole delayed-release 20 mg in healthy volunteers. Aliment Pharmacol Ther (2011) 1.61
Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis. Cancer Res (2001) 1.60
Selective abolition of the NMDA component of long-term potentiation in mice lacking mGluR5. Learn Mem (1999) 1.59
Focal fatty infiltration of the liver: analysis of prevalence and CT findings in children and young adults. AJR Am J Roentgenol (2001) 1.59
Effect of a lipidic extract from lepidium meyenii on sexual behavior in mice and rats. Urology (2000) 1.56
The ligamento-muscular stabilizing system of the spine. Spine (Phila Pa 1976) (1998) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
The role of genetic abnormalities of PTEN and the phosphatidylinositol 3-kinase pathway in breast and ovarian tumorigenesis, prognosis, and therapy. Semin Oncol (2001) 1.56
A quantitative description of the ground-state wave function of Cu(A) by X-ray absorption spectroscopy: comparison to plastocyanin and relevance to electron transfer. J Am Chem Soc (2001) 1.55
Identification of the first trans-(3R,4R)- dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid kappa receptor antagonist activity. J Med Chem (2001) 1.54
Anti-epidermal growth factor receptor monoclonal antibody 225 up-regulates p27KIP1 and induces G1 arrest in prostatic cancer cell line DU145. Cancer Res (1996) 1.54
Template-assisted self-assembly: a practical route to complex aggregates of monodispersed colloids with well-defined sizes, shapes, and structures. J Am Chem Soc (2001) 1.52
Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis. Cancer Res (1998) 1.52
Proliferative activity of calcifying odontogenic cysts as evaluated by proliferating cell nuclear antigen labeling index. Pathol Int (1998) 1.51
Proximal femoral density and geometry measurements by quantitative computed tomography: association with hip fracture. Bone (2006) 1.51
Contiguous patches of normal human mammary epithelium derived from a single stem cell: implications for breast carcinogenesis. Cancer Res (1996) 1.51
Trophoblast functions, angiogenesis and remodeling of the maternal vasculature in the placenta. Mol Cell Endocrinol (2002) 1.50
A comparison between bromodeoxyuridine and 3H thymidine labeling in human breast tumors. Mod Pathol (1991) 1.50
Mutations affecting the development of the peripheral nervous system in Drosophila: a molecular screen for novel proteins. Genetics (2000) 1.49
Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancers. Clin Cancer Res (1997) 1.48